Search
01/03/2026
Initial physician experience with MOSES Raydar™: A bench test to discover the potential of fiber-stone proximity approximation
Pietropaolo, A, Kamphuis, G, Angerri, O, Benelli, A, Khan, F, Shaw, M, Chaussee, E, Shachrai, I, Birman, T, Venkatraman, G, Turney, B. Initial physician experience with MOSES Raydar™: A bench test to discover the potential of fiber-stone proximity approximation. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Expanding the donor pool: Multicentric outcomes of kidney transplantation from donors with small renal tumors
Garcia, CM, Ajami, T, Sierra, A, Payet, G, Francès, A, Etcheverry, B, Gómez,, Alvarez-Maestro, M, Medina, J, Rodriguez-Fava, O, Ide, P, Checcini, L, Fiol, M, Peri, L, Alcaraz, A, Musquera, M. Expanding the donor pool: Multicentric outcomes of kidney transplantation from donors with small renal tumors. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
Guide for quality control and safety in clinical linear accelerators?
Manzano, PA, Rey, EA, Gracia, CF, Albaladejo, MM, Fernández, JPA, Oliver, RT, Pacheco, MV, Valverde, FL. Guide for quality control and safety in clinical linear accelerators?. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2026; 143DOI:10.1016/j.ejmp.2026.105747. PMID:41679132. IF:2.700(Q2/4D).
01/03/2026
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Blauvelt, A, Strober, BE, Eakin, GS, Howard, LM, Langan, C, van de Kerkhof, PCM, Puig, L, Lebwohl, MG, Romiti, R, Armstrong, AW, Choon, SE, Ramessur, R, Gelfand, JM, Merola, JF, Winthrop, KL, Torres, T. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; 94(3)DOI:10.1016/j.jaad.2025.11.033. PMID:41260526. IF:11.800(Q1/1D).
01/03/2026
Economic Burden of Hidradenitis Suppurativa in Spain
Vilarrasa, E, Borrás-Blasco, J, Lobo-Benito, S, Loro-Pérez, M, Núñez-García, MG, Oliva-Moreno, J, Palacios-Martínez, D, Rubial-Bernárdez, F, Ivanova-Markova, Y, Daheron, M, Bellas, J, Martorell, A. Economic Burden of Hidradenitis Suppurativa in Spain. Dermatology and Therapy. 2026; 16(3)DOI:10.1007/s13555-026-01669-2. PMID:41723775. IF:4.200(Q1/1D).
01/03/2026
Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions
Diaz, AFM, Henriquez, JDS, Ojeda, CM, Medina, AA, Duran, PD, Serrano, GM, Dos Santos, VG, Krajewski, W, Pichler, R, Scilipoti, P, Longoni, M, De Angelis, M, Moschini, M, Velasco, JC, Aumatell, J, Contieri, R, Gallioli, A, Slusarczyk, A, Grobet-Jeandin, E, Del Giudice, F, Soria, F, Mertens, L, Pradere, B, Revilla, FJB. Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).